Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GPR84 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | ARHGAP15 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-05 |
mRNA | MAML3 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | TDRD9 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | TGS1 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | MFSD2B | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | C16orf82 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | PLEK | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
mRNA | ANGEL2 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | MTR | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |